Report
Jeremy Garnier

Orège : Unsurprising 2022 results, pending new strategic plan

>2022 sales of € 3.5m (vs € 4m est.) and EBIT of -€ 4.7m (vs -€ 4m est.) - Orège’s 2022 results, reported yesterday, were close to our estimates. Sales came in at € 3.5m (vs € 4m est.), up 53%. EBIT is still in negative territory, at -€ 4.7m (vs -€ 4m est.) with the group yet to achieve critical mass and with ongoing significant R&D work related to the new Orège solutions to improve the yield of anaerobic digestion systems. Net income came to -€ 6.2m (vs -€ 4.7m est.)...
Underlying
Orege SA

Orege SA is a France-based company active in the environmental industry. The Company offers solutions of the treatment of effluents, such as wastewater and sludge, for industrials in the oil and gas, petrochemical and chemical sectors, as well as for the food and beverage and municipals industries. It provides water treatment units, which are later operated by customers in partnership with the Company, and water purification services, which involve the setting up for a determined period of time (from one month to over a year depending on the case) of a treatment on the customers site for one-off treatment work. In March 2014, Eren's stake in the Company increased up to 69.22% of capital and 60.52% of voting rights as result of takeover bid launched together with certain shareholders. In March 2014, Eren SA acquired 48.9% of the Company.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Jeremy Garnier

Other Reports on these Companies
Other Reports from Oddo BHF
Matthias Desmarais
  • Matthias Desmarais

ResearchPool Subscriptions

Get the most out of your insights

Get in touch